Market News | Tue Nov 3, 2015 | 7:57am EST
BRIEF-GSK CEO sees Nucala, Shingrix, anaemia pill, antivirals as pipeline highlights
Nov 3 Glaxosmithkline Plc CEO on media call:
* Calls out Nucala for severe asthma, Shingrix for shingles as exciting products, along with daprodustat in anaemia and drugs for viral diseases
* says respiratory medicine will probably not be as important part of company in future
* says no target figure for research and development spending, has moved investment from fixed assets to projects
* says very confident company has resources to fund current pipeline  Further company coverage:    
